Azithromycin Sodium Dihydrogen Phosphate (Qilu Pharmaceutical)

阿奇霉素磷酸二氢钠 (齐鲁制药)

Report date: 2026/03/04 20:01:44

Base Information

Drug NameAzithromycin Sodium Dihydrogen Phosphate (Qilu Pharmaceutical)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsRespiratory Tract Infections
Global Approved IndicationsRespiratory Tract Infections
Approved Indications in ChinaRespiratory Tract Infections
Original Approved Country/TerritoryMainland China
Original Approved Date2002/09/30
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesQilu Pharmaceutical Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesQilu Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsRespiratory Tract Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A